Venkat R Katkoori
Overview
Explore the profile of Venkat R Katkoori including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
353
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mughal J, Katkoori V, Nidorf S, Manu M, Abela G
Am Heart J Plus
. 2025 Mar;
51:100509.
PMID: 40046649
Cholesterol crystals (CCs) released into the coronary circulation during plaque rupture have multiple adverse impacts on both the arterial conduit as well as the myocardium. CCs form within the atheromatous...
2.
Abela G, Katkoori V, Pathak D, Bumpers H, Leja M, Abideen Z, et al.
Am Heart J Plus
. 2023 Nov;
35.
PMID: 37981958
Background And Aims: Cancer and atherosclerosis share common risk factors and inflammatory pathways that promote their proliferation via vascular endothelial growth factor (VEGF). Because CCs cause mechanical injury and inflammation...
3.
Katkoori V, Manne U, Chaturvedi L, Basson M, Haan P, Coffey D, et al.
Oncotarget
. 2017 Nov;
8(44):76574-76586.
PMID: 29100333
Background: The codon 72 polymorphism in p53 has been implicated in colorectal cancer (CRC) risk, prognosis and CRC health disparities. We examined the functional consequence of this polymorphism in CRC....
4.
Jia X, Shanmugam C, Paluri R, Jhala N, Behring M, Katkoori V, et al.
Oncotarget
. 2017 Apr;
8(12):20198-20212.
PMID: 28423626
Background: Although loss of heterozygosity (LOH) at chromosome location 18q21 and decreased expression of SMAD4 in invasive colorectal cancers (CRCs) correlate with poor patient survival, the prognostic value of LOH...
5.
Council L, Shanmugam C, Suswam E, Katkoori V, Heslin M, Hanna A, et al.
J Dig Dis Hepatol
. 2017 Feb;
2016(5).
PMID: 28203651
Objective: To investigate the clinical value of p53 codon 72 single nucleotide polymorphisms (SNPs) and variants of adenomatous polyposis coli (APC) in hepatocellular carcinomas (HCCs). Methods: DNA and RNA from...
6.
Katkoori V, Basson M, Bond V, Manne U, Bumpers H
Oncotarget
. 2015 Aug;
6(29):27763-77.
PMID: 26318034
The Nef-M1 peptide competes effectively with the natural ligand of CXC chemokine receptor 4 (CXCR4), stromal cell-derived factor 1-alpha, to induce apoptosis and inhibit growth in colon cancer (CRC) and...
7.
Bovell L, Shanmugam C, Putcha B, Katkoori V, Zhang B, Bae S, et al.
Clin Cancer Res
. 2013 May;
19(14):3955-65.
PMID: 23719259
Purpose: MicroRNAs (miRNA) have potential prognostic value for colorectal cancers; however, their value based on patient race/ethnicity and pathologic stage has not been determined. The goal was to ascertain the...
8.
Vogtmann E, Shanmugam C, Katkoori V, Waterbor J, Manne U
J Gastrointest Oncol
. 2013 Mar;
4(1):40-4.
PMID: 23450636
Background: Low socioeconomic status (SES) has been associated with abnormal expression of p53 in breast cancer, but this relationship has not been evaluated for colorectal cancer (CRC). A cohort of...
9.
Katkoori V, Suarez-Cuervo C, Shanmugam C, Jhala N, Callens T, Messiaen L, et al.
J Gastrointest Oncol
. 2012 Jul;
1(2):76-89.
PMID: 22811811
Objective: Since the anti-tumor activity of 5-fluorouracil (5-FU) is due to induction of apoptosis, we assessed the value of expression of key apoptotic molecules (Bax, Bcl-2 and p53) in predicting...
10.
Katkoori V, Shanmugam C, Jia X, Vitta S, Sthanam M, Callens T, et al.
PLoS One
. 2012 Jan;
7(1):e30020.
PMID: 22276141
Although the prognostic value of p53 abnormalities in Stage III microsatellite stable (MSS) colorectal cancers (CRCs) is known, the gene expression profiles specific to the p53 status in the MSS...